Physician profile
Mary E Johnson
NPI 1992944904
$379.75
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $142 · 2023: $50.69 · 2024: $31.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.74 | 2021-2023 | Relistor |
| Merck Sharp & Dohme LLC | $51.51 | 2021-2022 | |
| Eisai INC. | $50.52 | 2021 | |
| Arbor Pharmaceuticals, INC. | $39.79 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $36.62 | 2022-2023 | Ztlido |
| Organogenesis INC. | $31.08 | 2024 | Cygnus Dual, Puraply Am |
| Biogen, INC. | $20.13 | 2021 | |
| Athena Bioscience, LLC | $18.96 | 2023 | Qdolo |
| Bioventus LLC | $16.99 | 2021 | |
| Pacira Therapeutics, INC. | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.